Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial
- Resource Type
- Article
- Source
- In
Immuno-Oncology and Technology June 2024 22 - Subject
- Language
- ISSN
- 2590-0188